BDNF 196 G/A and 270 C/T Polymorphisms and Susceptibility to Parkinson's Disease: A Meta-Analysis

ABSTRACT The aim of this study was to explore whether brain-derived neurotrophic factor (BDNF) polymorphisms 196 G/A and 270 C/T confer susceptibility to Parkinson's disease (PD). The authors conducted a meta-analysis of the associations between the BDNF 196 G/A and 270 C/T polymorphisms and PD in subjects. They considered 12 studies in the case of the BDNF 196 G/A polymorphism and 4 studies in the case of the BDNF 270 C/T polymorphism. Meta-analysis showed no association between PD and the BDNF 196A allele in all study subjects (odds ratio [OR] = 1.066, 95% CI [0.972, 1.169], p = .173). However, ethnicity-specific meta-analysis identified an association between the BDNF 196 AA + AG genotype and PD in Europeans, but not in Asians (OR = 1.212, 95% CI [1.007, 1.458], p = .042; OR = 1.0567, 95% CI [0.913, 1.221], p = .465). Meta-analysis showed no association between PD and the BDNF 270 C/T polymorphism (OR for the T allele = 1.213, 95% CI [0.923, 1.595], p = .165). This meta-analysis identified an association between the BDNF 196 G/A polymorphism in Europeans, but not in Asians, but failed to identify an association between the BDNF 270 C/T polymorphism and PD.

[1]  R. Djaldetti,et al.  Contribution of genetic variants to pain susceptibility in Parkinson disease , 2012, European journal of pain.

[2]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[3]  P. Chan,et al.  Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease. , 2012, Parkinsonism & related disorders.

[4]  Z. Katsarou,et al.  Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with Parkinson’s disease in a Greek population , 2011, Journal of Clinical Neuroscience.

[5]  Weiguo Liu,et al.  The 712A/G polymorphism of Brain-derived neurotrophic factor is associated with Parkinson's disease but not Major Depressive Disorder in a Chinese Han population. , 2011, Biochemical and biophysical research communications.

[6]  J. López-Barneo,et al.  Brain‐derived neurotrophic factor G196A polymorphism and clinical features in Parkinson’s disease , 2010, Acta neurologica Scandinavica.

[7]  D. Forero,et al.  Exploration of genetic susceptibility factors for Parkinson’s disease in a South American sample , 2010, Journal of Genetics.

[8]  E. Beghi,et al.  BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease , 2009, European journal of neurology.

[9]  D. Weinberger,et al.  BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson’s disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[10]  Yih-Ru Wu,et al.  Nuclear receptor NR4A2 IVS6 +18insG and brain derived neurotrophic factor (BDNF) V66M polymorphisms and risk of Taiwanese parkinson's disease , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[11]  A. Singleton,et al.  BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups , 2007, Neuroscience Letters.

[12]  T. Gillis,et al.  Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington’s disease , 2006, Neurobiology of Disease.

[13]  T. Lehtimäki,et al.  No association between the brain-derived neurotrophic factor 196G>A or 270C>T polymorphisms and Alzheimer’s or Parkinson’s disease , 2006 .

[14]  J. Harley,et al.  Meta-analysis of TNF-α promoter −308 A/G polymorphism and SLE susceptibility , 2006, European Journal of Human Genetics.

[15]  H. Shill,et al.  BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study , 2005, Neurology.

[16]  J. Harley,et al.  The mannose-binding lectin gene polymorphisms and systemic lupus erythematosus: two case-control studies and a meta-analysis. , 2005, Arthritis and rheumatism.

[17]  Y. Lee,et al.  Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis , 2005, Human Genetics.

[18]  Elias Zintzaras,et al.  The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis , 2005, Journal of Human Genetics.

[19]  R. Kaji,et al.  Brain‐derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy , 2005, Movement disorders : official journal of the Movement Disorder Society.

[20]  Mariza de Andrade,et al.  Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[21]  T. Robbins,et al.  The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson’s disease , 2005, Journal of Neurology.

[22]  M. Rundle,et al.  Association of variations in monoamine oxidases A and B with Parkinson's disease subgroups. , 2004, Genomics.

[23]  S. Tsai,et al.  Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset , 2003, Neuroscience Letters.

[24]  H. Inoko,et al.  Toward identification of susceptibility genes for sporadic Parkinson’s disease , 2003, Journal of Neurology.

[25]  Y. Itoyama,et al.  Association between a polymorphism of brain‐derived neurotrophic factor gene and sporadic Parkinson's disease , 2003, Annals of neurology.

[26]  A. Oliviero,et al.  Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease: Evidence of impaired glutamatergic neurotransmission? , 2003, Annals of neurology.

[27]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[28]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[29]  Ichiro Kanazawa,et al.  Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms , 2002, Annals of neurology.

[30]  R. Heumann,et al.  Synaptic secretion of BDNF after high‐frequency stimulation of glutamatergic synapses , 2001, The EMBO journal.

[31]  M. Murer,et al.  Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.

[32]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[33]  G. Yancopoulos,et al.  BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra , 1991, Nature.

[34]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[35]  J. Rinne,et al.  No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease. , 2006, Folia neuropathologica.

[36]  J. Harley,et al.  Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. , 2006, European Journal of Human Genetics.